局部鼻腔类固醇用于儿童腺增大:系统性审查和元分析
Asher T Ripp1, Ethan M Kallenberger2, Shaun A Nguyen2
1Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, USA; SUNY Downstate College of Medicine, Brooklyn, NY, USA.
International journal of pediatric otorhinolaryngology
|October 7, 2025
概括
鼻内皮质类固醇 (INCS) 有效地治疗儿童腺增大 (AH),减少像鼻腔阻塞这样的症状. 这一元分析显示,INCS显著降低了AH的严重程度,并可能降低了腺切除手术的需要.
科学领域:
- 儿科耳鼻喉科 儿科耳鼻喉科
- 过敏和免疫学 过敏和免疫学
背景情况:
- 腺体缩 (AH) 是一种常见的儿科疾病,导致鼻腔阻塞和睡眠呼吸障碍.
- 目前对症状性AH的治疗包括手术和各种医疗干预措施,结果各不相同.
研究的目的:
- 进行全面的元分析,评估鼻内皮质类固醇 (INCS) 治疗儿童腺缩症的疗效.
主要方法:
- 按照PRISMA指南进行系统审查和元分析.
- 包括的研究评估了INCS的儿科AH与对照组.
- 在Cochrane,SCOPUS,PubMed和CINAHL数据库中进行了搜索.
主要成果:
- 分析了16项涉及1156名儿童的研究,636名接受INCS,520名为对照.
- INCS显著减少了严重的AH (降低了-43.5%与-13.3%,p < 0.0001).
- INCS改善了鼻腔阻塞和 (p < 0.05) 并降低了腺切除术的发生率 (22.3%与98.6%,p < 0.0001).
结论:
- 鼻内皮质类固醇是有效的管理儿科腺增大和相关症状.
- INCS 改善了对AH的主观和客观测量,可能减少在特定情况下需要手术干预的需要.
相关概念视频
Upper Respiratory Drugs: Decongestants
823
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
823
Adrenergic Agonists: Mixed-Action Agents
1.4K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.4K
Drugs Used in Upper Respiratory Disorders: Overview
626
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
626
Adrenergic Agonists: Therapeutic Classification
1.4K
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
1.4K
Adrenergic Agonists: Direct-Acting Agents
2.6K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
2.6K
Adrenergic Agonists: Therapeutic Uses
1.7K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.7K


